The federal government’s decision to slash $500 million in funding for mRNA vaccine research has sparked concern among health ...

A long list of medical experts are saying Robert F. Kennedy Jr.'s decision to cut mRNA research will set back the country’s ...

Kennedy’s $500M cut to mRNA funding puts startups at risk and imperils one of life sciences’ few leasing bright spots.

President Trump’s laissez-faire approach is notable, given that the development of the Covid vaccine was seen as one of his ...

US Health Secretary Robert F. Kennedy Jr. cited false claims to justify terminating 22 federal contracts for mRNA-based ...

Stocks in the health-care industry rose as markets grew more confident that U.S. borrowing costs will fall, while companies in the sector pleased investors in their quarterly reports. Gilead Sciences ...

An official overseeing implementation of the Make America Healthy Again agenda at the Department of Health and Human Services ...

The tussle had centred on the development of mRNA jab technology, which was at the forefront of the fight against Covid-19.

HHS Secretary Robert F. Kennedy Jr.’s decision to cut $500 million in federal funding for mRNA vaccine development is based ...

GSK is set to receive up to $500 million and 1% royalties on future vaccine sales following the settlement of a US patent dispute between CureVac NV, Pfizer, and BioNTech SE.

HHS officials are citing an extensive list of studies purported to document harms caused by mRNA vaccines as scientific ...